Malaysiakini
NEWS

Gilead's remdesivir gets US FDA approval for hospitalised Covid-19 patients

Reuters

Published

COVID-19 | The US Food and Drug Administration (FDA) on Thursday approved Gilead Sciences Inc's antiviral drug, remdesivir for treating patients hospitalised with Covid-19, making it the first and only drug approved for the disease in the United States.

Remdesivir, given intravenously, was one of the drugs used to treat US President Donald Trump during his bout with Covid-19.

All Access Plan

from

~RM12

per month
Unlimited access to our articles
Comment on all our stories
Gift articles to your friends
Subscribe Now
You can cancel anytime.
Secure and Encrypted
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In